InterOcean Capital’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-4,460
Closed -$273K 176
2017
Q4
$273K Buy
+4,460
New +$279K 0.04% 140
2017
Q1
Sell
-11,028
Closed -$644K 152
2016
Q4
$644K Hold
11,028
0.14% 74
2016
Q3
$595K Buy
11,028
+7,265
+193% +$467K 0.14% 74
2016
Q2
$277K Buy
+3,763
New +$266K 0.07% 117
2016
Q1
Sell
-2,992
Closed -$206K 149
2015
Q4
$206K Buy
+2,992
New +$198K 0.07% 130

Other funds holding BMY

InterOcean Capital's BMY Position: Q1 2018 in Review

InterOcean Capital sold out of Bristol-Myers Squibb (BMY) in Q1 2018, closing a stake of 4,460 shares — an estimated $273K sold.

InterOcean Capital first reported a position in BMY in Q4 2015 and held it in 5 quarters. The position peaked at $644K in Q4 2016. 1,746 funds tracked by Wall St. Rank hold BMY as of Q1 2018.

  • InterOcean Capital reported no remaining Bristol-Myers Squibb position as of Q1 2018 after selling out during the quarter.
  • InterOcean Capital sold 4,460 Bristol-Myers Squibb shares in Q1 2018, an estimated $273K.
  • InterOcean Capital first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 5 quarters.
  • InterOcean Capital's Bristol-Myers Squibb position peaked at $644K in Q4 2016.
  • 1,746 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2018.

Based on InterOcean Capital's 13F filing for Q1 2018, filed 15 May 2018.